Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 68
Filter
1.
Internist (Berl) ; 60(2): 133-140, 2019 02.
Article in German | MEDLINE | ID: mdl-30617701

ABSTRACT

Current guidelines for specialized treatment of diabetes mellitus in the elderly (>65 years old) are primarily based on epidemiologic studies and geriatric assessment of functional health. Yet, age-dependent alterations of glucose metabolism and homeostasis are highly relevant to the pathophysiology of diabetes in the elderly. In this review, we focus on age-related alterations in metabolic pathways and their relevance for the specialized diabetic care in the elderly. We review the role of increasing insulin resistance, age-related ß­cell dysfunction and incretin secretion. The clinical relevance of these effects will also be discussed in regard to the central geriatric syndrome of sarcopenia and antidiabetic drug therapy.


Subject(s)
Aging/metabolism , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/blood , Insulin Resistance , Muscle Proteins/metabolism , Sarcopenia , Aged , Aging/physiology , Diabetes Mellitus, Type 2/drug therapy , Glucose/metabolism , Humans , Hypoglycemic Agents/administration & dosage , Insulin
2.
Sci Rep ; 8(1): 5894, 2018 04 12.
Article in English | MEDLINE | ID: mdl-29650978

ABSTRACT

Patients with non-valvular atrial fibrillation (AF) and a high risk for oral anticoagulation can be treated by percutaneous implantation of left atrial appendage occlusion devices (LAAC) to reduce the risk of cardio-embolic stroke. This study evaluates whether LAAC may influence lipid metabolism, which has never been investigated before. Patients with successful LAAC were included consecutively. Venous peripheral blood samples of patients were collected immediately before (T0, baseline) and 6 months after (T1, mid-term) LAAC. A targeted metabolomics approach based on electrospray ionization liquid chromatography-mass spectrometry (ESI-LC-MS/MS) and MS/MS measurements was performed. A total of 34 lipids revealed a significant change from baseline to mid-term follow-up after successful LAAC. Subgroup analysis revealed confounding influence by gender, age, diabetes mellitus type II, body mass index, left ventricular ejection fraction, creatinine and NT-proBNP. After multivariable adjustment within logistic regression models, these 34 lipids were still significantly altered after LAAC. Successful percutaneous LAAC may affect lipid metabolism and thereby may potentially affect pro-atherogenic and cardio-toxic effects.


Subject(s)
Atrial Appendage/metabolism , Atrial Fibrillation/blood , Diabetes Mellitus, Type 2/blood , Lipids/blood , Metabolome , Percutaneous Coronary Intervention/methods , Age Factors , Aged , Aged, 80 and over , Atrial Appendage/diagnostic imaging , Atrial Appendage/surgery , Atrial Fibrillation/complications , Atrial Fibrillation/diagnostic imaging , Atrial Fibrillation/surgery , Body Mass Index , Creatinine/blood , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/diagnostic imaging , Diabetes Mellitus, Type 2/surgery , Echocardiography, Transesophageal , Female , Humans , Lipid Metabolism , Lipids/classification , Logistic Models , Male , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Prospective Studies , Risk Factors , Sex Factors , Spectrometry, Mass, Electrospray Ionization , Stroke Volume/physiology , Tandem Mass Spectrometry
3.
Z Gerontol Geriatr ; 51(5): 579-584, 2018 Jul.
Article in English | MEDLINE | ID: mdl-28233118

ABSTRACT

Gout develops in four stages beginning with an asymptomatic increase in blood levels of uric acid. An acute gout attack is an expression of an underlying inflammatory process, which in the course of time is self-limiting. Without therapy monosodium urate crystals remain in the synovial fluid and synovial membrane and trigger more acute attacks. In the course of the disease monosodium urate crystals form deposits (tophi) leading in severe forms to irreversible joint deformities with loss of functionality. In 20% of cases gout leads to involvement of the kidneys. Overproduction of uric acid can cause nephrolithiasis. These stones can be composed of uric acid or calcium phosphate. Another form of kidney disease caused by gout is uric acid nephropathy. This is a form of abacterial chronic inflammatory response with deposition of sodium urate crystals in the medullary interstitium. Acute obstructive nephropathy is relatively rare and characterized by renal failure due to uric acid precipitation in the tubules because of rapid cell lysis that occurs, for example, with chemotherapy. There is a causal interdependence between the occurrence of hyperuricemia and hypertension. Uric acid activates the renin-angiotensin-aldosterone (RAA) system and inhibits nitric oxide (NO) with the possible consequence of a rise in systemic vascular resistance or arteriolar vasculopathy; however, uric acid is also an apparently independent risk factor for atherosclerosis. In contrast to young patients, the diagnosis of an acute gout attack in the elderly can be a challenge for the physician. Polyarticular manifestations and obscure symptoms can make it difficult to differentiate it from rheumatoid arthritis and calcium pyrophosphate deposition disease (CPPD). Aspiration of synovial fluid with visualization of urate crystals using compensated polarized light microscopy is the gold standard for diagnosis of acute gout. Moreover, analysis of synovial fluid enables a distinction from septic arthritis by Gram staining and bacterial culture. Soft tissue ultrasonography is useful to detect affected synovial tissue and monosodium urate crystals within the synovial fluid. Involvement of bone occurs relatively late in the disease so that x­ray images are not useful in the early stages but might be helpful in differential diagnostics. Dual energy computed tomography (CT) and magnetic resonance imaging (MRI) can be used for certain indications.


Subject(s)
Arthritis/physiopathology , Calcium Pyrophosphate/blood , Chondrocalcinosis/diagnosis , Gout/diagnosis , Uric Acid/blood , Aged , Calcium , Chondrocalcinosis/blood , Chondrocalcinosis/immunology , Diagnosis, Differential , Gout/immunology , Humans , Hyperuricemia/complications
4.
Z Gerontol Geriatr ; 51(4): 453-460, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28233117

ABSTRACT

Gout and calcium pyrophosphate deposition disease (CPPD, pseudogout) are still the most frequent inflammatory arthritides in multimorbid elderly patients. Gout and CPPD are different diseases and based on different pathophysiological principles. Gout is closely associated with the metabolic syndrome and is an independent risk factor for cardiovascular mortality. The prevalence of asymptomatic hyperuricemia is estimated to be 10-20% of adults in industrial nations and prevalence is strongly associated with age. More than 7% of persons aged over 65 years suffer from clinically manifest gout. The underlying pathophysiological principle is an imbalance between the formation and elimination of uric acid. The degradation of the purine bases adenine and guanosine to uric acid is catalysed by xanthine oxidase and genetic polymorphisms and mutations play an important role in absorption and excretion processes. Furthermore, carrier proteins, such as URAT-1 or OAT-4 also have an influence on these processes. An imbalance of the physiological processes results in the solubility product being exceeded, which in consequence leads to crystallization of urate. This induces a cascade of massive inflammatory reactions at the molecular and cellular level with the activation of cytokines. The inflammatory process can be stopped by neutrophil extracellular traps (NETs) that modulate aggregation and degradation of chemokines and cytokines and partitioning of crystallized urate against immune cells. Calcium pyrophosphate dehydrate (CPP) crystals are formed in the cartilage and CPP deposition can be found in 30% of people aged over 80 years. Inorganic pyrophosphate (PPi) is synthesized in chondrocytes and plays an important part in the formation of calcium pyrophosphate crystals. The degradation is catalyzed by inorganic pyrophosphatases. If there is dysregulation of this homeostasis more PPi is produced, which ultimately contributes to the formation of the CPP crystals.


Subject(s)
Calcium Pyrophosphate/adverse effects , Chondrocalcinosis/epidemiology , Chondrocalcinosis/physiopathology , Gout/epidemiology , Gout/physiopathology , Aged , Aged, 80 and over , Calcium , Calcium Phosphates/adverse effects , Calcium Phosphates/metabolism , Calcium Pyrophosphate/metabolism , Chondrocalcinosis/blood , Crystallization , Gout/blood , Humans , Uric Acid
5.
Z Gerontol Geriatr ; 51(6): 703-710, 2018 Aug.
Article in English | MEDLINE | ID: mdl-28246893

ABSTRACT

The treatment of gout is based on several principles. Symptom control and termination of the inflammatory process are important early goals, whereas the urate level should be lowered in the long term to prevent further gout attacks and complications. The non-pharmacological approach is based on individually informing the patient on dietary measures and changes of life style. Besides physical measures, such as cold applications on the affected joint, various medications are available for treatment of an acute gout attack. The choice of drug depends on the individual risk profile. If non-steroidal anti-inflammatory drugs (NSAID) and coxibs are chosen it should be taken into account that the use is restricted in patients with renal insufficiency. Moreover, these drugs may have gastrointestinal side effects and are associated with increased cardiovascular morbidity and mortality. Colchicine has gastrointestinal side effects at high dosages but can also be used for differential diagnostics if there is a quick response to treatment. Steroids are an effective alternative and can be given orally or parenterally in patients with dysphagia. Moreover, steroids can be used in cases of renal insufficiency. After symptoms of the acute attack have subsided, urate lowering therapy should be initiated to prevent further attacks. Low-dose urate lowering therapy can be started during an acute gout attack when acute therapy is initiated. Allopurinol is still the medication of choice but its use is restricted in patients with renal insufficiency. A rare but serious side effect is allopurinol hypersensitivity syndrome. Febuxostat can be an alternative in patients who do not tolerate allopurinol. In February 2016, lesinurad, an URAT-1 and OAT-4 inhibitor, was approved in combination with allopurinol or febuxostat. Data on the effectiveness and safety of synthetic uricases and biologicals are still sparse for elderly patients. These substances are reserved for severe cases of gout.


Subject(s)
Calcium Pyrophosphate , Gout Suppressants , Gout , Aged , Arthritis , Calcium , Gout/drug therapy , Gout Suppressants/therapeutic use , Humans , Uric Acid
6.
Pneumologie ; 71(3): 151-163, 2017 Mar.
Article in German | MEDLINE | ID: mdl-28196386

ABSTRACT

Personalized, individualized, targeted therapy has successfully found entrance in the palliative treatment of lung cancer as they enable a personalized and individualized strategy going ahead with biomarker testing. Due to the crescending amount of predictive molecular and immunhistochemical analyses at different time points during therapy the need for more and actual tumor tissue increases; however these samples cannot always be obtained without major discomfort for the patients. Therefore, analyses from blood, the so called "liquid biopsy", is an alternative or additional method. Activating mutations in the EGFR gene and the inhibitory mutation T790 M can already be detected from blood during clinical routine. This review presents the status of liquid biopsy for diagnosis, prognosis and as predictive parameter during the course of therapy in lung cancer and gives an outlook on future developments.


Subject(s)
Biomarkers, Tumor/blood , Lung Neoplasms/blood , Lung Neoplasms/diagnosis , Neoplasm Proteins/metabolism , Pathology, Molecular/methods , Algorithms , Biopsy/methods , Evidence-Based Medicine , Humans , Reproducibility of Results , Sensitivity and Specificity
7.
J Nutr Health Aging ; 20(9): 918-926, 2016.
Article in English | MEDLINE | ID: mdl-27791222

ABSTRACT

OBJECTIVES: The aims of this study were to determine the prevalence of malnutrition in patients of a geriatric day hospital using the Mini Nutritional Assessment short form (MNA-SF) and the full MNA, to compare both tools, and to examine the relationship between nutritional and functional status. DESIGN: Cross-sectional study. SETTING: Geriatric day hospital. PARTICIPANTS: 190 patients (72.1% female, median 80 years) aged 65 years or older. MEASUREMENTS: In consecutively admitted geriatric day hospital patients nutritional status was assessed by MNA-SF and full MNA, and agreement between both tools calculated by Cohen´s kappa. Basic activities of daily living (ADL), instrumental activities of daily living (IADL) and short physical performance battery (SPPB) were determined and related to MNA categories (Chi2-test, Mann-Whitney-U-test). RESULTS: 36.3 % and 44.7% of the patients were at risk of malnutrition, 8.9 % and 5.8 % were malnourished according to MNA-SF and full MNA, respectively. Agreement between both MNA forms was moderate (κ=0.531). No significant associations between MNA-SF and ADL, IADL and SPPB, and between full MNA and SPPB were observed. According to full MNA, the proportion of patients with limitations in ADL and IADL significantly increased with declining nutritional status (ADL: 2.1 vs. 8.2 vs. 18.2 %, p=0.044; IADL: 25.5 vs. 47.1 vs. 54.5 %, p=0.005) with a simultaneous decrease of the proportion of patients without limitations. Well-nourished patients reached significantly higher ADL scores than patients at risk of malnutrition (95 (90-100) vs. 95 (85-100), p=0.005) and significantly higher IADL scores than patients at risk or malnourished (8 (6-8) vs. 7 (5-8) vs. 6 (4-8), p=0.004). CONCLUSION: The high prevalence of risk of malnutrition and the observed association between functional status and nutritional status according to full MNA call for routine nutritional screening using this tool in geriatric day hospital patients.


Subject(s)
Geriatric Assessment , Nutrition Assessment , Nutritional Status , Activities of Daily Living , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Hospitalization , Humans , Male , Malnutrition/epidemiology , Patients , Prevalence , Risk
8.
Rofo ; 188(12): 1144-1150, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27643800

ABSTRACT

Purpose: Evaluation of the benefit of selective venous blood sampling (SVS) for the preoperative identification of parathyroid adenomas with unclear localization in non-invasive diagnostics. Materials and Methods: In a retrospective study, all patients (n = 23) with primary (n = 21) or tertiary (n = 2) hyperparathyroidism were evaluated from 2005 to 2016 at the Hospital Nuremberg-North. These patients all received one (n = 20) or more (n = 3) SVS. 15 patients had one or more previous unsuccessful surgeries (group A), 8 patients received the SVS primarily before the first surgery (group B). Results of SVS were compared with the results of surgery, non-invasive diagnostic procedures and clinical follow up. Results: In 24 out of 26 SVS a significant PTH peak was found. 19 patients underwent surgery after SVS. In 16 of these cases (84 %) the SVS peak was concordant with the intraoperative localization. Thus, SVS of all operated patients had a sensitivity of 94 %. Considering only patients with prior HPT surgery the sensitivity was 89 %. In none of the 26 examinations complications occurred. Conclusion: Our results demonstrate that selective venous blood sampling SVS in cases with unclear imaging of parathyroid adenomas is an effective and low-risk invasive diagnostic method to localize parathyroid adenomas and helps to improve surgical therapy. Key points: • low risk invasive diagnostic procedure to localize parathyroid adenomas• additional step if non-invasive diagnostics are negative or inconclusive• high sensitivity in the detection of parathyroid adenomas Citation Format: • Hader C, Uder M, Loose RWR et al. Selective Venous Blood Sampling for Hyperparathyroidism with unclear Localization of the Parathyroid Gland. Fortschr Röntgenstr 2016; 188: 1144 - 1150.


Subject(s)
Adenoma/blood , Hyperparathyroidism/blood , Parathyroid Neoplasms/blood , Phlebotomy/methods , Radiography, Interventional/methods , Veins/diagnostic imaging , Adenoma/complications , Adenoma/diagnostic imaging , Adult , Aged , Female , Humans , Hyperparathyroidism/diagnostic imaging , Hyperparathyroidism/etiology , Male , Middle Aged , Parathyroid Glands/diagnostic imaging , Parathyroid Neoplasms/complications , Parathyroid Neoplasms/diagnostic imaging , Reproducibility of Results , Retrospective Studies , Sensitivity and Specificity
9.
Med Klin Intensivmed Notfmed ; 111(5): 458-62, 2016 Jun.
Article in German | MEDLINE | ID: mdl-26440099

ABSTRACT

ß-Blockers and calcium channel blockers are commonly used drugs in the treatment of atrial fibrillation with tachycardia. However, in patients with high myocardial susceptibility and vulnerability, combination therapy with ß-blockers and non-dihydropyridine calcium channel blockers (verapamil or diltiazem) but also individual administration can cause drug-induced cardiogenic shock. Thus, the simultaneous administration of ß-blockers and non-dihydropyridine calcium channel blockers is absolutely contraindicated. In case of acute heart failure, isolated application is also contraindicated. In the treatment of a cardiogenic shock induced by ß-blockers and/or non-dihydropyridine calcium channel blockers, administration of intravenous calcium, glucagon or high-dose insulin is recommended.


Subject(s)
Atrial Fibrillation/drug therapy , Carbazoles/adverse effects , Carbazoles/therapeutic use , Critical Care/methods , Propanolamines/adverse effects , Propanolamines/therapeutic use , Shock, Cardiogenic/chemically induced , Tachycardia/drug therapy , Verapamil/adverse effects , Verapamil/therapeutic use , Aged, 80 and over , Carvedilol , Drug Interactions , Drug Therapy, Combination , Female , Humans , Infusions, Intravenous
12.
Horm Metab Res ; 45(11): 795-801, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23996518

ABSTRACT

It is indefinite whether nonalcoholic steatohepatitis (NASH) results as by-product from general metabolic perturbations and adipokine dysregulations or whether defined dietary factors also play a pathogenetic role. Here, we examine the effects of a modification of dietary lipids in a NASH inducing diet on metabolic changes as well as hepatic steatosis, inflammation, and fibrosis in rats. Male Wistar rats were fed with variations of the atherogenic diet (AD), which induces pathophysiological changes resembling human NASH. Dietary variants (AD without cholesterol, cholate, or choline; change of neutral fat to olive oil or coconut oil) were fed for 8 weeks. Insulin resistance, adipokine profile, liver histology, and lipid content as well as expression of proinflammatory and profibrogenic genes were examined. AD led to clear signs of hepatic steatosis and inflammation together with an increase in TNF and collagen type 1 expression. AD without cholesterol showed markedly less liver damage without changes of insulin action and adipokine profile. AD with olive oil and AD without cholate clearly attenuated hepatic inflammation, whereas fat deposition and features of the metabolic syndrome were increased in these animals. Insulin resistance and hepatic fat deposition per se do not cause significant hepatic inflammation in this rodent model. However, dietary cholesterol is an important causal agent for the development of NASH. Olive oil plays a protective role in this respect, which might be due to the high content of monounsaturated fatty acids.


Subject(s)
Fatty Liver/drug therapy , Insulin Resistance , Plant Oils/therapeutic use , Adipokines/metabolism , Animals , Cholesterol , Diet , Disease Models, Animal , Fatty Liver/blood , Fatty Liver/chemically induced , Fatty Liver/genetics , Fibrosis/genetics , Gene Expression Regulation/drug effects , Glucose/metabolism , Humans , Inflammation/genetics , Liver/drug effects , Liver/enzymology , Liver/pathology , Male , Non-alcoholic Fatty Liver Disease , Olive Oil , Plant Oils/pharmacology , Rats , Rats, Wistar , Transaminases/metabolism , Triglycerides/blood , Weight Gain/drug effects
13.
Z Gerontol Geriatr ; 46(5): 403-9, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23780630

ABSTRACT

OBJECTIVE: Low vitamin D blood levels are highly prevalent in elderly people, particularly in nursing home residents (NHR). A relation between vitamin D levels and physical function (PF) is described in several studies in older adults; however, data on NHR are scarce and there is presently no information on the time course of vitamin D levels and PF in this population. The aim of the present study was to describe the 25-hydroxyvitamin D [25(OH)D] status of NHR at baseline (t1) and after 1 year (t2) to examine whether 25(OH)D blood levels are related to PF at t1 and at t2, and whether changes in 25(OH)D levels over 1 year are related to changes in PF. METHODS: All NHR (≥ 65 years) without tube-feeding and severe acute or end-stage disease were asked to participate. At t1 and t2 fasting blood samples were taken for the analysis of 25(OH)D serum levels and PF was estimated by activities of daily living (Barthel ADL) and measured by handgrip strength (HGS) and timed 'up and go' test (TUG). RESULTS: In total, 115 residents, aged 87 (82-93) years (all data in median and 1st-3rd quartile), showed the following values for PF: ADL 50 (20-65) points, HGS 40 (30-50) kPa and TUG 26 (18-31) s. Vitamin D deficiency (< 50 nmol/l) was present in 93.9 % (70.4 % < 25 nmol/l) at t1 and in 71.2 % (57.3 % < 25 nmol/l) at t2. At t1 and at t2 a weak correlation between vitamin D level and PF (Spearman's correlation coefficient t1: ADL r = 0.367, HGS r = 0.313; t2: ADL: r = 0.247; all p < 0.01) was observed. There was no correlation between changes in vitamin D levels over 1 year and changes in PF. CONCLUSIONS: Almost all NHR included in the study showed vitamin D deficiency. 25(OH)D levels were weakly correlated to PF at baseline and at follow-up, and an increase in vitamin D levels was not associated with positive effects on PF in this study.


Subject(s)
Activities of Daily Living , Hand Strength , Motor Activity , Vitamin D Deficiency/epidemiology , Vitamin D Deficiency/physiopathology , Vitamin D/blood , Aged , Aged, 80 and over , Female , Germany/epidemiology , Health Services for the Aged , Humans , Longitudinal Studies , Male , Nursing Homes , Prevalence , Risk Factors , Treatment Outcome
14.
Clin Lab ; 59(1-2): 185-92, 2013.
Article in English | MEDLINE | ID: mdl-23505925

ABSTRACT

BACKGROUND: Reliable and precise CA 19-9 testing is required for the long-term follow-up of patients with pancreatic carcinoma during therapy. The aim of this longitudinal proficiency study was to evaluate the comparability, linearity, and precision of CA 19-9 determinations performed in different laboratories using currently available test systems under routine conditions. METHODS: During the one year study period, 15 laboratories applied 7 different tests and included a liquid BIOREF control serum with pancreatic carcinoma derived CA 19-9 in their routine testing and quality control procedures. The results were collected centrally and evaluated statistically. RESULTS: The comparability of CA 19-9 results is limited especially when different tests are used, albeit, some tests show a good correlation: The CA 19-9 values obtained by different laboratories using different test systems vary up to a factor of 2. The precision of CA 19-9 determinations was acceptable in most laboratories with coefficients of variation ranging between very low 3.2% and high 17.8%. The imprecision was slightly increased when automatic dilution procedures of the analysers were used. CONCLUSIONS: The comparability of CA 19-9 test results must be improved. The precision is acceptable in most cases. In order to monitor key performance parameters, every laboratory should participate in external quality assessment schemes and should perform a routine internal quality control with a control serum independent from the test kit manufacturer.


Subject(s)
Biomarkers, Tumor/blood , CA-19-9 Antigen/blood , Pancreatic Neoplasms/blood , Humans , Longitudinal Studies , Quality Control , Reproducibility of Results
15.
Z Gerontol Geriatr ; 46(6): 569-75, 2013 Aug.
Article in German | MEDLINE | ID: mdl-23242336

ABSTRACT

Contemporary geriatric research focuses mainly on observational clinical studies and epidemiological surveys and the translation of basic scientific results from biogerontology into a clinical context is often neglected. Following a definition of translational research the article gives an overview of recent key publications in experimental biogerontology with a special emphasis on their relevance for clinical geriatrics. The topics dealt with include age-induced loss of skeletal muscle (sarcopenia), the aging immune system (immunosenescence) and neurodegenerative disorders (Alzheimer's and Parkinson's disease).


Subject(s)
Delivery of Health Care/trends , Geriatrics/trends , Translational Research, Biomedical/trends , Animals , Humans
16.
Z Gerontol Geriatr ; 46(6): 563-8, 2013 Aug.
Article in German | MEDLINE | ID: mdl-23242337

ABSTRACT

Biological aging means a time-dependent accumulation of changes to which a living organism is being exposed during its lifetime. Biological aging normally concurs with chronological aging the time frame of which is set by an upper limit, the lifespan (in humans approximately 120 years). New findings in experimental biogerontology are challenging both the dogma of irreversibility of biological aging and the preset species-specific limitations of life. The present overview first explains the general principle of rejuvenation and reversal of biological aging with paradigms from stem cell research. Secondly, recent key publications on artificial telomerase elongation and (alleged) lifespan enhancement by sirtuins and resveratrol will be discussed with an emphasis on the implications for (future) geriatric medicine.


Subject(s)
Aging , Biomedical Research/trends , Geriatrics/trends , Life Expectancy/trends , Longevity , Stem Cell Research , Forecasting , Humans
17.
Z Gerontol Geriatr ; 45(6): 473-8, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22915001

ABSTRACT

INTRODUCTION: Polypharmacy is closely associated with multimorbidity in the elderly and can lead to problems and drug interactions. AIM: This study assessed polypharmacy in the elderly, tracking inquiries to the Poison Information Centre Nuremberg (PICN) and patients needing toxicological intensive care therapy. METHODS: From 2006-2009, all PICN inquiries involving individuals > 70 years were tracked, as were cases at the Toxicological Intensive Care Unit (T-ICU) regarding adverse drug reactions (ADRs) and drug poisoning. RESULTS: Of 11,683 PICN calls about pharmaceuticals, 175 (1.5%) were from people > 70 years; 156 (4.8%) of 3,272 T-ICU patients were > 70 years. Calls about psychopharmaceuticals (46.9%) and analgesics (25.7%) were most frequent. Among the T-ICU patients, psychopharmaceuticals like sedatives and hypnotics were frequently involved (20.5%), as were tricyclic antidepressants (17.9%) and analgesics (29.5%). Ethanol was co-ingested by 18.3%. CONCLUSION: Population-specific poison prevention strategies are needed to reduce toxic exposures. Such strategies could include pharmacist intervention, improved prescriber communication and education regarding the geriatric population, and computerized drug databases.


Subject(s)
Drug Interactions , Drug-Related Side Effects and Adverse Reactions/mortality , Poisoning/mortality , Polypharmacy , Aged , Aged, 80 and over , Drug-Related Side Effects and Adverse Reactions/prevention & control , Female , Germany/epidemiology , Humans , Incidence , Male , Poisoning/prevention & control , Risk Assessment , Risk Factors , Survival Analysis , Survival Rate
19.
Clin Lab ; 57(9-10): 669-75, 2011.
Article in English | MEDLINE | ID: mdl-22029181

ABSTRACT

BACKGROUND: The present proficiency study aimed to elucidate the comparability and reliability of test systems for the determination of AFP concentrations. METHODS: 25 laboratories using 8 different commercial test systems used liquid BIOREF-AFP control serum in their routine internal quality control over a period of one year. For statistical analysis the results were collected centrally. RESULTS: The statistical analysis of the test results revealed considerable variation for the different laboratories. The deviations of the mean values of different laboratories from the overall mean value varied between 0.1 and 26.1%, and for most of the laboratories the deviation was round about 10%. The precision of measured values in the individual laboratories was in most cases acceptable: Nevertheless, the coefficients of variation of the individual laboratories ranged from 13 to 16.1%. CONCLUSIONS: In conclusion, this study indicates that AFP results vary between different laboratories albeit an international standard for AFP is available. Therefore, every laboratory should participate in external ring studies and should use a quality control serum independent of the test kit manufacturer for the internal quality control.


Subject(s)
Clinical Laboratory Techniques/standards , Reagent Kits, Diagnostic/standards , alpha-Fetoproteins/analysis , Adult , Cell Line, Tumor , Clinical Laboratory Techniques/statistics & numerical data , Female , Humans , International Cooperation , Liver Neoplasms/blood , Liver Neoplasms/diagnosis , Male , Neoplasms, Germ Cell and Embryonal/blood , Neoplasms, Germ Cell and Embryonal/diagnosis , Pregnancy , Reference Values , Reproducibility of Results
20.
Z Gerontol Geriatr ; 44(3): 166-71, 2011 Jun.
Article in German | MEDLINE | ID: mdl-21573908

ABSTRACT

The early diagnosis of an acute myocardial infarction (MI) is improved by the introduction of novel high-sensitivity troponin assays. These assays can measure low level myocardial injury not detectable by standard troponin assays. Especially in older patients who appear to have a higher basal troponin level, the results must always be judged in the context of the medical history, physical examination, electrocardiogram (ECG) and any further findings. Even small increases in high-sensitivity troponin indicate increased risk for death or MI during follow-up. In the case of MI an invasive strategy results in better survival rates compared with conservative therapy but at the expense of an increased risk of bleeding in elderly patients. This article provides an overview on the diagnosis of MI in elderly patients.


Subject(s)
Electrocardiography/methods , Geriatric Assessment/methods , Medical History Taking/methods , Myocardial Infarction/diagnosis , Physical Examination/methods , Aged , Aged, 80 and over , Early Diagnosis , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...